Tekla Life Sciences Investors

$18.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.30 (+1.63%) Today
$0.00 (0.00%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell HQL and other stocks, options, and ETFs commission-free!

About HQL

Tekla Life Sciences Investors is a non-diversified closed-end healthcare fund, which engages in investing in the life sciences industry. The fund primarily invest in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, and healthcare information technology and services. The company was founded on May 8, 1992 and is headquartered in Boston, MA. The listed name for HQL is Tekla Life Sciences Investors.

CEO
Daniel R. Omstead
Employees
Headquarters
Boston, Massachusetts
Founded
1992
Market Cap
440.06M
Price-Earnings Ratio
37.16
Dividend Yield
7.76
Average Volume
71.22K
High Today
$18.77
Low Today
$18.50
Open Price
$18.50
Volume
58.65K
52 Week High
$19.28
52 Week Low
$11.45

Collections

You May Also Like